Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.
1 report, 1 independent
Updated Jun 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- MarketBeat highlighted Boston Scientific as a stock to watch on July 29, 2026.Sub-event
Boston Scientific and Avivagen compete in the medical device market.1 source
Keep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided analyst recommendations and compared Organon & Co. and Xeris Biopharma.
- Eton Pharmaceuticals and Biofrontera, small-cap healthcare companies, are noted for their revenue and earnings, with MarketBeat providing analyst ratings.
- MarketBeat reported analyst ratings for Maze Therapeutics, which utilizes the Compass platform, highlighting competition among healthcare companies.
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.